Home / Biotechnology / Drug Disco

Drug Discovery Technologies Market By Type (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics And Pharmacogenetics, Combinatorial Chemistry, Nanotechnology, Spectroscopy, Metabolomics) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Drug discovery is a process wherein new drugs are identified for any disease indication. Developing drug from the stage of discovery to market approval is a lengthy process which contribute to significant costs to the developers. Main focus of R&D is into identification of a target and discovery of some chemical candidates which can activate or block the target. The main reasons of drug failure are lack of efficacy and safety of discovered drug candidate, leading to financial losses to the companies. To inhibit such contingencies, the status of efficient drug discovery process have become critical in the field of drug development.

Major market drivers of drug discovery is globally expanding population, rising prevalence of diverse range of disease encompassing neurology, cardiovascular, oncology and other chronic disease areas. Some tropical infectious diseases are still in need of appropriate medical interventions. Pharmaceutical solutions are required to meet this challenge and also to overcome severe issues like antibiotic resistance. Number of ways are identified and being explored to strengthen the drug discovery technologies market in future years by facilitating patented innovation in free access platform, developing new metrices for capturing data of open research and reforming regulatory guidelines by assigning particular designation for products. Increasing research funding from governmental organizations and pharmaceutical manufacturers and patent expiration of marketed drugs are the major reasons behind the smooth progress of drug discovery technologies market worldwide. Introduction of new technologies is expected to escalate the market growth in coming years by efficiently identifying promising drug candidates and reducing the chances of failure.

Utilizing advanced tools such as text mining and machine learning to streamline the course of finding and developing new drug is predicted to boost the future drug discovery technologies market. The adoption of artificial intelligence tool and IT solution in drug discovery for speeding up research process is likely to influence overall drug discovery technologies market growth and industry landscape. However, overall huge expenses of drug discovery, delayed processing of stringent government regulations act as restraining factors to the market growth.

The purpose of this research study titled ‘Drug Discovery Technologies Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, industry experts, company executives and with exhaustive analysis to enable them to take vital strategic initiatives and decisions related to the prospects in the global drug discovery technologies market. This report encompasses key market dynamic factors of drug discovery such as driving forces, restraining factors, and major opportunities. This research report also delivers the predominant and future trends in the drug discovery technologies market which is projected through 2025 along with CAGR for the period of 2017-2025.

This report categorizes the global drug discovery technologies market in terms of technology type and geographical distribution. On the basis of drug discovery technologies type, the market has been segmented into high throughput screening, biochips, bioinformatics, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics and others (RNAi, proteomics, epigenetics, and chromatography). This research report offered cross-sectional analysis of each and every segment with base year (2016) data to gain better understanding of the market and forecasted through 2025 with CAGR considering 2017-2025.

Geographically, the drug discovery technologies market is segmented into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America Middle East and Africa
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

This report includes detailed profiling of major players of drug discovery technologies market with thorough explanation of competitive assessment tools like major agreements, acquisition and merger activities, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis. The major players profiled in this report are Abbott Laboratories, Inc., Novartis AG, Eli Lily, Affymetrix Inc, AstraZeneca plc., Boehringer Ingelheim, Inc., Bayer Healthcare AG, GlaxoSmithKline LLC., Pfizer Inc., Sanofi, Albany Molecular Research Inc., and Luminex Corporation.

 Drug Discovery Technologies Market

Geographically, the global drug discovery technologies market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drug Discovery Technologies Market

In the base year 2016, North America is estimated to be the most significant market for drug discovery technologies as the region is the hub of all major drug manufacturing companies. The adoption of recent advanced technologies is higher in North America, which in turn acts as driving force of the market growth. Increasing expenditure on R&D and promising policies encourage pharmaceutical companies to develop drugs. The United States being the leader in medical research produced more than half of drug molecules in the last decade. Launching of the fast-track scheme for drug approval, PRIME initiative by the European Medicine Agency is expected to augment drug discovery technologies market in this region.  Increasing initiatives for collaborative research projects and networking among industrial and academic experts, large pharmaceutical companies and medium or small sized enterprises are expected to support pharmaceutical development in Europe. European Lead Factory is a platform aiming to escalate drug discovery in Europe by providing access to academic institutions, small and medium enterprises with more than 500,000 novel chemical compounds and boost the drug discovery activities. Asia Pacific is a region of 60% of the world’s population. This region is expected to witness substantial growth due to the large targeted population as it offers a pool of potential clinical trials. Rising disease prevalence, increasing funding for research activities and improved regulatory guidelines regarding the clinical research are few of the major drivers of the drug discovery technologies market in Asia Pacific.

The global drug discovery technologies market is presented as follows:

  • North America (The United States & Canada)
  • Europe (The United Kingdom, Germany, and rest of European countries)
  • Asia Pacific (India, Japan, China, South Korea and rest of Asia Pacific countries)
  • Latin America (Mexico, Brazil, and rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa and rest of MEA countries)
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Published Date:  Dec 2017
Category:  Biotechnology
Report ID:   58927
Report Format:   PDF
Pages:   120
Rating:    4.2 (24)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support